International cooperation in Biotechnology: Business Delegation to UK 2026

Accompanying a German biotech delegation to the United Kingdom was an inspiring and highly rewarding experience for Alessandra. As project manager and delegation lead, she had the opportunity to support innovative German SMEs during an intensive programme focused on international cooperation, business development and strategic networking within one of Europe's leading life science ecosystems.

The UK continues to position itself as a major global biotech hub, with strong investment activity, world-class research institutions and a dynamic innovation environment. Recent industry reports and sector discussions highlight the resilience and growth potential of UK biotech, particularly in areas such as AI-driven drug discovery, advanced therapeutics and clinical innovation.

The programme included high-level networking opportunities, B2B meetings and participation in sector-specific events in London. One of the highlights was the interaction with leading UK stakeholders from the biotech, pharma and research communities, creating valuable opportunities for future German-UK collaboration. The delegation also connected with organisations involved in Bio Integrates and the wider UK life science ecosystem.

Beyond the business meetings, the trip once again demonstrated the importance of international exchange and trust-building between companies, institutions and innovation networks. Supporting companies during these market exploration activities means not only organising meetings, but also creating the right environment for meaningful conversations, long-term partnerships and practical cooperation.

Accompanying the delegation and contributing to stronger connections between the German and UK biotech sectors was a particularly valuable experience for our in2newmarkets team.

Hashtag: #UKBiotech #Biotech #LifeSciences #HealthcareInnovation #InternationalBusiness #BusinessDelegation #GermanSMEs #Networking #B2B #Innovation #MarketEntry #UKMarket #Internationalisation #Pharma #ResearchAndInnovation #BioTechIndustry #MadeInGermany #CrossBorderCooperation